Skip to content
  • Facebook
  • Twitter
This translation is automatically provided by Google; please refer to the original English version for appropriate wording.
Take on Typhoid

Take on Typhoid

  • Home
  • Why Typhoid?
    • Typhoid & Related Salmonelloses
    • Global Research
    • Links & Resources
  • The Issues
    • Vaccines
    • WASH
    • Drug-Resistant Typhoid
    • Treatment
    • Diagnostics
    • Related Issues
  • Resources & Tools
    • Talk About Typhoid
    • Global Policy
    • Country Tools
    • Infographics
    • Fact Sheets
    • TCV Cost-effectiveness
    • Share on Social
  • Blog & News
    • Blog
    • News
    • Publications
    • Newsletter
  • International Conference
    • 13th Conference Resources
    • Past Conferences
    • Conference Travel
  • About Us
    • About the Coalition against Typhoid
    • About the Typhoid Vaccine Acceleration Consortium

Extremely drug-resistant typhoid in south Asia

Posted on August 30, 2018 by admin

AUTHOR

Sophie Cousins

Click here to view the article, published in The Lancet.

Post navigation

Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance
The analysis of GM (1, 1) grey model to predict the incidence trend of typhoid and paratyphoid fevers in Wuhan City, China.

Newsletter Signup

Recent Posts

  • Time to take action with TCV in India

  • How can Zimbabwe mitigate the risk of typhoid amid a drought?

  • What have we learned from a 5-year-long study on typhoid conjugate vaccination in Bangladesh?

  • What do we know about typhoid intestinal perforation?

  • Reflections from the 2024 Asia Regional Meeting on Typhoid and TCV

cat
685 West Baltimore Street, Room 480
Baltimore, MD 21201-1509
Coalition against Typhoid
2175 K Street, NW, Suite 400
Washington, DC 20037
© 2018. Coalition Against Typhoid. All Rights Reserved.
  • Contact Us
  • Privacy Policy
  • Facebook
  • Twitter
Top